Data / Drug companies / Procainamide hydrochloride
Procainamide hydrochloride: 10 companies and 15 products in the FDA NDC directory
Procainamide hydrochloride is listed in the FDA National Drug Code Directory by 10 companies, with 15 products in commercial distribution. 15 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection, and the newest product started marketing on February 17, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 10
- Products
- 15
- Generic (ANDA) products
- 15 (100.0%)
- Application numbers
- 5
- Routes
- Intramuscular, Intravenous
- openFDA record search
- api.fda.gov
Companies that list procainamide hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Caplin Steriles Limited | 2 | injection, solution | Generic drugs (ANDA) | February 17, 2025 |
| Gland Pharma Limited | 2 | injection, solution | Generic drugs (ANDA) | July 22, 2024 |
| Medical Purchasing Solutions, LLC | 2 | injection, solution | Generic drugs (ANDA) | January 15, 2025 |
| Nexus Pharmaceuticals LLC | 2 | injection | Generic drugs (ANDA) | October 14, 2007 |
| Sagent Pharmaceuticals | 2 | injection, solution | Generic drugs (ANDA) | January 15, 2025 |
| HF Acquisition Co LLC, DBA HealthFirst | 1 | injection | Generic drugs (ANDA) | June 23, 2023 |
| Hospira, Inc. | 1 | injection, solution | Generic drugs (ANDA) | March 8, 2006 |
| International Medication Systems, Limited | 1 | injection | Generic drugs (ANDA) | December 21, 2016 |
| ProPharma Distribution | 1 | injection | Generic drugs (ANDA) | December 21, 2016 |
| Remedyrepack Inc. | 1 | injection | Generic drugs (ANDA) | October 10, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 9 | 60% |
| Injection | 6 | 40% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 15 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Antiarrhythmic | 15 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.